Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus - Concepedia

Concepedia

Publication | Closed Access

Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus

169

Citations

7

References

2005

Year

J. Neal Sharpe, Eugene H. Shively, Hiram C. Polk

The American Journal of Surgery

Methicillin-resistant Staphylococcus AureusEconomic OutcomesAntibioticsHealth SciencesHealthcare-associated InfectionLower-extremity SkinAntimicrobial ChemotherapyInfection ControlMedicineClinical MicrobiologyProsthetic Joint InfectionsAntimicrobial ResistanceDrug Resistance

References

	Year	Citations

Page 1